SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-17-040261
Filing Date
2017-06-19
Accepted
2017-06-19 21:58:20
Documents
1
Period of Report
2017-06-15

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 5737
  Complete submission text file 0001104659-17-040261.txt   7131
Mailing Address C/O MILLENNIUM PHARMACEUTICALS INC 40 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
BATE KENNETH (Reporting) CIK: 0001210238 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34186 | Film No.: 17919733

Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Issuer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations